Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Haematologica·2026
Same author

Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.

Nature communications·2026
Same author

Editorial: Unraveling the complexities of premature aging: mechanisms and interventions.

Frontiers in aging·2026
Same author

Modulating AP-1 enables CAR T cells to establish an intratumoral stemlike reservoir and overcomes resistance to PD-1 blockade.

Science immunology·2026
Same author

NKTR-255, a polymer-conjugated IL-15, synergizes with CAR-T cell therapy to activate endogenous anti-tumor immunity and improve tumor control.

bioRxiv : the preprint server for biology·2025
Same author

The prevalence of ENPP1 deficiency in humans with Ossification of the Posterior Longitudinal Ligament and the preclinical efficacy of ENPP1 enzyme therapy in murine Ossification of the Posterior Longitudinal Ligament.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025

Related Experiment Video

Updated: Apr 7, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

965

Engineering CAR-T cells: Design concepts.

Shivani Srivastava1, Stanley R Riddell1

  • 1Program in Immunology, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109, USA.

Trends in Immunology
|July 15, 2015
PubMed
Summary

Chimeric antigen receptor (CAR) T-cell therapy shows promise for blood cancers but needs improvement for solid tumors. Understanding T-cell receptor (TCR) signaling principles can enhance CAR design for better safety and efficacy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Biotechnology

Background:

  • Chimeric antigen receptor (CAR) T-cell therapy has achieved success in treating B cell malignancies.
  • Current CAR T-cell therapy faces challenges in safety, efficacy, and application to epithelial cancers.
  • T-cell receptor (TCR) signaling involves complex mechanisms beyond CD3ζ and CD28 phosphorylation that regulate T-cell function.

Purpose of the Study:

  • To explore how fundamental T-cell receptor (TCR) recognition principles can inform the design of improved chimeric antigen receptor (CAR) T-cell therapies.
  • To enhance the safety and efficacy of CAR T-cell therapy for a broader range of cancers, including solid tumors.

Main Methods:

  • Review and analysis of T-cell receptor (TCR) signaling pathways.
  • Examination of TCR recognition principles: spatial constraints, binding kinetics (Kon/Koff rates), and immunological synapse formation.

More Related Videos

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.1K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.2K

Related Experiment Videos

Last Updated: Apr 7, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

965
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

16.1K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.2K

  • In-depth analysis of existing CAR signaling mechanisms.

    • Main Results:

    • TCR signaling intricacies, including spatial and kinetic parameters, significantly impact T-cell differentiation and effector functions.
    • Applying TCR recognition principles offers a framework for designing next-generation CARs.
    • Potential for developing safer and more effective synthetic receptors for tumor targeting.

    Conclusions:

    • Leveraging a deeper understanding of TCR signaling can overcome current limitations in CAR T-cell therapy.
    • Optimizing CAR design based on TCR principles may lead to enhanced T-cell persistence, activation, and tumor control.
    • This approach holds promise for expanding CAR T-cell therapy to epithelial cancers and improving patient outcomes.